Skip to main content
. 2018 Oct 29;8(2):e1532763. doi: 10.1080/2162402X.2018.1532763

Figure 5.

Figure 5.

Effects of ONCOS-102 and pembrolizumab on number of liver nodules in each mouse at time of sacrifice (day 40). Data represent mean ± SEM. Groups: 1–6 had 8 animals/group, groups: 7–8 had 6 animals/group.